Nebraska 2025 2025-2026 Regular Session

Nebraska Legislature Bill LB41 Introduced / Fiscal Note

Filed 03/27/2025

                    PREPARED BY: Mikayla Findlay 
LB 41 DATE PREPARED: March 27, 2025 
PHONE: 	402-471-0062 
    
Revision: 02  
Revised to include provisions of AM 62 and AM 637 FISCAL NOTE 
 	LEGISLATIVE FISCAL ANALYST ESTIMATE 
 
ESTIMATE OF FISCAL IMPACT – STATE AGENCIES 	(See narrative for political subdivision estimates) 
 	FY 2025-26 	FY 2026-27 
EXPENDITURES REVENUE EXPENDITURES REVENUE 
GENERAL FUNDS     
CASH FUNDS 	$78,575  	$80,515  
FEDERAL FUNDS 	$105, 025  $103,085  
OTHER FUNDS     
TOTAL FUNDS 	$183,600  $183,600  
 
Any Fiscal Notes received from state agencies and political subdivisions are attached following the Legislative Fiscal Analyst Estimate. 
 
This bill would require an additional two pregnancy-related screenings for syphilis, during the third trimester and at birth, in addition to 
the existing screening requirement during the first gestational examination. The implementation date would be three months following 
adjournment and for the purposes of this fiscal note is assumed to be July 1, 2025. AM 62 adds provisions that specify that providers 
shall inform recipients that such testing is voluntary 	may be declined verbally or in writing. A M 637 states legislative intent that the state 
fund portion of such testing for individuals covered by Medicaid shall be sourced from the Medicaid Managed Care Excess Profit F	und. 
Note that revenue to the Medicaid Managed Care Excess Profit Fund is not guaranteed and lack of funding from this source may result 
in additional General Fund liabilities due to the required 	additional service of tests. 
 
These additional screening requirements would affect Medicaid coverage for pregnancies. The agency fiscal impact is based on an 
estimate of cost per test of $12. The Department of Health and Human Servi	ces (DHHS) notes that in FY24 there were 8,912 births 
under the Medicaid program. Currently, individuals who are deter	mined to be high risk already qualify for additional syphilis testing. 
Data on how many pregnant 	Medicaid clients in Nebraska are currently receiving additional testing is not available	. The agency 
estimated cost of $216,000 is based on $24 for two tests for 9,000 individuals. This fiscal note assumes a total of 1 5% of current 
Medicaid pregnancies already qualify for additional testing due to risk. As such, the assumed population is 7,650 and at $24 for two 
additional tests the cost is $186,600. The fund mix based on a proportional blend of CHIP, regular Medicaid, and Medicaid expansion 
federal participation. The state share is higher in FY27 	due to expected reduction in Federal Medical Assistance Percentage (FMAP).